U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. RETHYMIC
  1. Vaccines, Blood & Biologics

STN: 125685
Proper Name: allogeneic processed thymus tissue–agdc
Tradename: RETHYMIC
Manufacturer: Enzyvant Therapeutics GmbH
Indication:

  • For immune reconstitution in pediatric patients with congenital athymia.

Product Information

  • Package Insert - RETHYMIC
  • Demographic Subgroup Information – allogeneic processed thymus tissue-agdc
    Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Related Information

Back to Top